Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mark Longer"'
Publikováno v:
Drug Development and Industrial Pharmacy. 22:603-608
AG337 is a novel thymidylate synthase inhibitor possessing potent antitumorogenic activity which was designed using protein structure-based techniques. It is currently undergoing clinical trials as both N and oral formulations. Based on AG337's short
Publikováno v:
Journal of pharmaceutical sciences. 84(9)
AG1343 is a novel human immunodeficiency virus (HIV) protease inhibitor designed using protein structure-based techniques and intended for chronic oral administration in the treatment of AIDS-related conditions. The compound is the mesylate salt of a